Residency · Residency · Anesthesiology

Obesity and Anesthesia: Respiratory, Pharmacologic, and Logistic Challenges

Introduction

Obesity affects over 40% of adults in the United States and is increasingly prevalent worldwide. The World Health Organization defines obesity as a BMI of 30 kg/m2 or greater, with morbid obesity at a BMI of 40 kg/m2 or greater. The obese patient presents multisystem challenges that demand modifications in airway management, drug dosing, ventilatory strategy, positioning, and postoperative care.

Respiratory Physiology in Obesity

Altered Lung Mechanics

The most clinically significant respiratory change in obesity is the reduction in FRC, which may fall below closing capacity, causing airway closure during tidal breathing. Expiratory reserve volume and total lung capacity are also reduced. Chest wall elastance increases due to adipose tissue loading on the thorax and abdomen. The work of breathing increases, with oxygen consumption of the respiratory muscles rising to 2 to 4 times normal. Spirometry shows a restrictive pattern with a preserved or mildly reduced FEV1/FVC ratio.

Rapid Desaturation

Reduced FRC means diminished oxygen reserve during apnea. Safe apnea time in morbidly obese patients may be as short as 1 to 2 minutes compared to 6 to 8 minutes in lean patients despite adequate preoxygenation. Supine positioning further reduces FRC by 50% compared to the upright position.

Obstructive Sleep Apnea (OSA)

OSA is present in up to 70% of morbidly obese patients, often undiagnosed. The STOP-BANG questionnaire is a screening tool, with a score of 5 or greater indicating high probability of moderate-to-severe OSA. OSA patients have heightened sensitivity to opioids and sedatives and are at increased risk of postoperative respiratory complications including hypoxemia, reintubation, and ICU admission.

Obesity Hypoventilation Syndrome (OHS)

OHS is defined by a BMI of 30 or greater with daytime hypercapnia (PaCO2 above 45 mmHg) in the absence of other causes. It has a prevalence of 10 to 20% among obese patients with OSA and is associated with pulmonary hypertension and right heart failure. OHS carries higher perioperative morbidity and mortality than OSA alone.

Pharmacologic Considerations

Drug Dosing in Obesity

Several body weight scalars are used for drug dosing in obesity. Total body weight (TBW) is the actual measured weight. Ideal body weight (IBW) is based on height and sex, calculated as height in cm minus 100 for males or minus 105 for females. Lean body weight (LBW) is TBW minus fat mass. Adjusted body weight (ABW) is calculated as IBW + 0.4 x (TBW - IBW).

Dosing Recommendations by Drug Class

Volatile Anesthetic Selection

Desflurane is the preferred volatile agent because it has the lowest blood-gas and fat-gas solubility coefficients. It provides faster emergence and recovery compared to sevoflurane or isoflurane, with reduced risk of prolonged sedation from fat depot accumulation.

Airway Management

Anticipated Difficulties

Obese patients have a higher incidence of difficult mask ventilation and difficult intubation. Predictors include a neck circumference above 40 cm, Mallampati class III/IV, limited neck extension, and OSA. Redundant pharyngeal tissue and a large tongue contribute to airway compromise.

Optimization Strategies

The ramped position elevates the head and shoulders so that the external auditory meatus is level with the sternal notch ("sniffing on a ramp"). Preoxygenation should consist of 3 to 5 minutes of tidal breathing at 100% FiO2 in a 25-degree head-up position. CPAP or high-flow nasal oxygen during preoxygenation recruits alveoli and extends apnea time. Nasal oxygenation during efforts to secure a difficult airway (the NO DESAT technique) uses high-flow nasal cannula at 15 L/min during laryngoscopy. Video laryngoscopy should be used as the first-line device, and supraglottic airway, bougie, and surgical airway equipment should be immediately available.

Intraoperative Ventilatory Management

Lung-protective ventilation is employed with tidal volumes of 6 to 8 mL/kg calculated from IBW (not TBW). PEEP of 8 to 12 cmH2O maintains FRC above closing capacity. Recruitment maneuvers using sustained inflation to 40 cmH2O for 10 to 40 seconds are followed by PEEP application. Reverse Trendelenburg positioning (20 to 30 degrees) improves respiratory mechanics during abdominal surgery. Plateau pressures should be monitored and targeted below 30 cmH2O. Pressure-controlled ventilation should be considered if peak pressures are excessive with volume-controlled mode.

Logistic and Positioning Challenges

Operating tables have weight limits (standard tables approximately 200 kg, bariatric tables up to 450 kg). Appropriate bariatric equipment must be ensured, including wider blood pressure cuffs, longer spinal and epidural needles, and reinforced OR tables. Adequate padding of pressure points is essential because of the increased risk of rhabdomyolysis from prolonged compression. Rhabdomyolysis risk increases with surgery duration beyond 4 hours, BMI above 40, and lateral or lithotomy positions. Ultrasound-guided peripheral IV placement or central venous access may be needed for venous access. Thromboprophylaxis is critical because obese patients are at elevated risk for VTE, requiring both mechanical and pharmacologic prophylaxis.

Postoperative Considerations

Extubation should occur with the patient fully awake in the semi-upright position. Continuous pulse oximetry should be used for at least 24 to 48 hours in patients with OSA. An opioid-sparing multimodal analgesia strategy should include regional anesthesia, acetaminophen, NSAIDs, ketamine, and dexmedetomidine. Early ambulation reduces atelectasis and VTE risk. Postoperative CPAP should be considered in patients with known or suspected OSA.

Clinical Pearls

The most important respiratory change in obesity is the reduction in FRC, which leads to rapid desaturation during apnea; the clinician should always preoxygenate in the head-up position and consider apneic oxygenation techniques. Neuromuscular blockers should be dosed to IBW but sugammadex must be dosed to TBW; under-dosing sugammadex is a common and dangerous error. Ramped positioning is not optional in morbid obesity because it dramatically improves the laryngoscopic view and should be set up before induction. Desflurane offers the fastest and most predictable emergence profile in obese patients due to its low tissue solubility.

References

1. Nightingale CE, Margarson MP, Shearer E, et al. Peri-operative management of the obese surgical patient 2015. Anaesthesia. 2015;70(7):859-876.
2. De Jong A, Wrigge H, Hedenstierna G, et al. How to ventilate obese patients in the ICU. Intensive Care Med. 2020;46(12):2423-2435.
3. Ingrande J, Brodsky JB, Lemmens HJM. Lean body weight scalar for the anesthetic induction dose of propofol in morbidly obese subjects. Anesth Analg. 2011;113(1):57-62.
4. Jense HG, Dubin SA, Silverstein PI, O'Leary-Escolas U. Effect of obesity on safe duration of apnea in anesthetized humans. Anesth Analg. 1991;72(1):89-93.

Read this lecture as Markdown